Mach; Jean-Pierre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mach; Jean-Pierre.The latest application filed is for "multispecific antibodies".

Company Profile

3.9.15

Mach; Jean-Pierre - Bellevue CH
Mach; Jean-Pierre - Lausanne CH
Mach; Jean-Pierre - Epalinges CH
Mach, Jean-Pierre - CH-1293 Bellevue CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multispecific Antibodies App 20210040235 - Kadouche; Jean ; et al.	2021-02-11
Multispecific Antibodies App 20200385490 - Kadouche; Jean ; et al.	2020-12-10
Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains Grant 10,815,310 - Kadouche , et al. October 27, 2	2020-10-27
Multispecific Antigens Binding Fragments And Multispecific Antibodies Derived Therefrom Comprising Mutant Ch1 And Cl-kappa Domains App 20180022829 - Kadouche; Jean ; et al.	2018-01-25
Targeted CD1d molecules Grant 9,809,654 - Robert , et al. November 7, 2	2017-11-07
MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES App 20170312356 - DONDA; Alena ; et al.	2017-11-02
Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-.kappa. domains Grant 9,631,031 - Kadouche , et al. April 25, 2	2017-04-25
Modulation of NKT cell activity with antigen-loaded CD1d molecules Grant 9,603,922 - Donda , et al. March 28, 2	2017-03-28
Novel Hemoglobin-derived Peptide Based Pharmaceutical Compositions App 20160184404 - HEINI; Adrian ; et al.	2016-06-30
Multispecific Mutated Antibody Fab Fragments App 20140242076 - Kadouche; Jean ; et al.	2014-08-28
Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components Grant 7,968,103 - Westphal , et al. June 28, 2	2011-06-28
Method for the oligomerisation of peptides App 20100105876 - Terskikh; Alexey ; et al.	2010-04-29
Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules App 20080254045 - DONDA; Alena ; et al.	2008-10-16
Compositions Comprising Fetal Hemoglobin and Bacterial Endotoxin and Optionally Additional Fetal Liver Components App 20080075742 - Westphal; Otto ; et al.	2008-03-27
Multicomponent conjugates which bind to target molecules and stimulate T cell lysis App 20070237771 - Donda; Alena ; et al.	2007-10-11
Targeted cd1d molecules App 20060269540 - Robert; Bruno ; et al.	2006-11-30
Peptabody for cancer treatment App 20060233808 - Deperthes; David ; et al.	2006-10-19
Multicomponent conjugates which bind to target molecules and stimulate T cell lysis App 20040143094 - Donda, Alena ; et al.	2004-07-22
Multicomponent conjugates which bind to target molecules and stimulate cell lysis App 20040068100 - Mach, Jean-Pierre ; et al.	2004-04-08
Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen Grant 5,047,507 - Buchegger , et al. September 10, 1	1991-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.